Lixte Biotechnology Holdings, Inc.
LIXT • NASDAQ • Stock Fundamentals
Lixte Biotechnology Holdings, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Geordan G. Pursglove, with a market cap of $126.1M.
Market Cap$126.1M
Employees4.0
CEOGeordan G. Pursglove
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 1 month agoQ1 2026
View reportFinancials
Based on Q1 2026 filing
Lixte Biotechnology Holdings, Inc. FAQ
Common questions about Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. (LIXT) has a market capitalization of $126.1M and trades on NASDAQ.
Lixte Biotechnology Holdings, Inc. has approximately 4 employees.